Vimpat 50 mg/1 (Lacosamide TABLET, FILM COATED) 50 mg/1

Vimpat 50 mg is an oral medication used to manage certain types of seizures. This film-coated tablet contains lacosamide, a compound known for its anticonvulsant properties. Ideal for those seeking effective seizure control, Vimpat is manufactured by UCB, Inc. in the USA.

Strength

50 mg/1

Pack Size

1 BLISTER PACK in 1 CARTON (0131-2477-99) / 14 TABLET, FILM COATED in 1 BLISTER PACK

Manufacturer / TM Owner

UCB, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Vimpat 50 mg is primarily used as an adjunctive therapy for the treatment of partial-onset seizures in adults and children aged 4 years and older. Lacosamide, the active ingredient, works by stabilizing electrical activity in the brain, which can help reduce the frequency and severity of seizures. This medication is often prescribed when other treatments have not been fully effective.

Side Effects

Common effects of Vimpat 50 mg may include dizziness, headache, and nausea. Some users might experience fatigue or double vision. These effects vary among individuals and are generally mild to moderate in nature. It's important to monitor any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

Vimpat 50 mg should be handled with care, especially by individuals with a history of heart conditions or psychiatric disorders. It is essential to follow the prescribed dosage and administration instructions. Pregnant or breastfeeding women should discuss the potential risks and benefits with their healthcare provider before starting this medication.

Avoid Interactions

Vimpat 50 mg may interact with other medications, including those that affect the central nervous system. Alcohol and certain antidepressants can enhance the sedative effects of lacosamide. It's advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Vimpat 50 mg is used as an adjunctive treatment for partial-onset seizures in adults and children aged 4 years and older.

Vimpat 50 mg should be taken orally, following the dosage instructions provided by your healthcare provider.

Common side effects include dizziness, headache, nausea, fatigue, and double vision.

Vimpat 50 mg may interact with other medications, so it's important to consult your healthcare provider before combining it with other treatments.

Pregnant women should discuss the potential risks and benefits of Vimpat 50 mg with their healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.